Drug-resistance amino acids known in HIV-1 [36] are shown in bold. Amino acids that are the same as those of the reference HIV-1 HXB2 are shown as bars. † Consensus amino acid sequences were ...

For people with drug-resistant infections, a monoclonal antibody came out in 2018 for use along with other HIV medications.

Now new laboratory work in Canada sheds light on the vulnerabilities of HIV's pockets of resistance in the body, and potential ways to thwart them. Led by Université de Montréal medical ...

The drug has been shown to be effective at preventing HIV infection but does not cure an existing HIV infection.

A new long-acting preventive HIV drug could reach the world’s poorest countries by the end of 2025 or early 2026, a global ...

Added to this is the escalating threat of antimicrobial resistance (AMR) and major gaps in the response to pediatric HIV. The growing rollback of human rights and gender equality globally ...

However, researchers acknowledge it is likely that the two participants in the lenacapavir group who contracted HIV developed a certain resistance from the sole use of lenacapavir. This may need ...

Darwin Tenoria first learned about HIV when he was on his deathbed. He was 27 and weighed just 70 pounds. "I died for two minutes and I was revived in the hospital," he remembers. When he woke up ...

"In the cases of HIV cure, the patients received donor immune cells that were resistant to HIV infection because the donor cells lacked a protein that HIV requires to infect the cell," she said.